Literature DB >> 34311759

Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.

Nahid Sarahian1, Hosna Sarvazad2, Elham Sajadi3, Nasrin Rahnejat4, Narges Eskandari Roozbahani5.   

Abstract

BACKGROUND: The most common endocrine and metabolic disorders in premenopausal women is polycystic ovary syndrome (PCOS), characterized by hyperandrogenism, chronic anovulation, and/or ultrasound evidence of small ovarian cysts. Obesity and insulin resistance are also the main factors influencing the clinical manifestations of this syndrome. Alzheimer's disease (AD) is the most typical progressive neurodegenerative disorder of the brain, and recent studies suggest a relationship between endocrinal dysregulation and neuronal loss during AD pathology. AIM: This study aimed to evaluate the common risk factors for Alzheimer's and PCOS based on previous studies. Knowing the common risk factors and eliminating them may prevent neurodegenerative Alzheimer's disease in the future.
METHOD: In this narrative review, international databases, including Google Scholar, Scopus, PubMed, and the Web of Science, were searched to retrieve the relevant studies. The relevant studies' summaries were categorized to discuss the possible pathways that may explain the association between Alzheimer's and PCOS signs/symptoms and complications.
RESULTS: According to our research, the factors involved in Alzheimer's and PCOS disorders may share some common risk factors. In patients with PCOS, increased LH to FSH ratio, decreased vitamin D, insulin resistance, and obesity are some of the most important factors that may increase the risk of Alzheimer's disease.
© 2021. The Author(s).

Entities:  

Keywords:  Alzheimer disease; Hyperandrogenism; Insulin resistance; Polycystic ovary syndrome; Review

Year:  2021        PMID: 34311759     DOI: 10.1186/s12978-021-01203-x

Source DB:  PubMed          Journal:  Reprod Health        ISSN: 1742-4755            Impact factor:   3.223


  104 in total

Review 1.  Alzheimer's disease.

Authors:  Alistair Burns; Steve Iliffe
Journal:  BMJ       Date:  2009-02-05

Review 2.  The Mechanisms of Action of Curcumin in Alzheimer's Disease.

Authors:  Mengxi Tang; Changiz Taghibiglou
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 3.  Brain sex matters: estrogen in cognition and Alzheimer's disease.

Authors:  Rena Li; Jie Cui; Yong Shen
Journal:  Mol Cell Endocrinol       Date:  2014-01-11       Impact factor: 4.102

Review 4.  Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome.

Authors:  Juan Wang; Daichao Wu; Hui Guo; Meixiang Li
Journal:  Life Sci       Date:  2019-10-08       Impact factor: 5.037

5.  Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.

Authors:  An-Tao Du; Norbert Schuff; Joel H Kramer; Howard J Rosen; Maria Luisa Gorno-Tempini; Katherine Rankin; Bruce L Miller; Michael W Weiner
Journal:  Brain       Date:  2007-03-12       Impact factor: 13.501

Review 6.  Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction.

Authors:  Frank González
Journal:  Steroids       Date:  2011-12-08       Impact factor: 2.668

7.  Are women with polycystic ovary syndrome (PCOS) at higher risk for development of Alzheimer disease?

Authors:  Behnam Sabayan; Farzaneh Foroughinia; Afshin Borhani Haghighi; Arash Mowla
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Jul-Sep       Impact factor: 2.703

Review 8.  Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review.

Authors:  Fang-Fang He; Yu-Mei Li
Journal:  J Ovarian Res       Date:  2020-06-17       Impact factor: 4.234

9.  Corrigendum to "Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction".

Authors:  Hernán Gonzalo Villagarcía; Vanesa Sabugo; María Cecilia Castro; Guillermo Schinella; Daniel Castrogiovanni; Eduardo Spinedi; María Laura Massa; Flavio Francini
Journal:  Int J Endocrinol       Date:  2018-10-23       Impact factor: 3.257

10.  The worldwide costs of dementia 2015 and comparisons with 2010.

Authors:  Anders Wimo; Maëlenn Guerchet; Gemma-Claire Ali; Yu-Tzu Wu; A Matthew Prina; Bengt Winblad; Linus Jönsson; Zhaorui Liu; Martin Prince
Journal:  Alzheimers Dement       Date:  2016-08-29       Impact factor: 21.566

View more
  2 in total

Review 1.  The Systemic Effects of Exercise on the Systemic Effects of Alzheimer's Disease.

Authors:  Dora Aczel; Bernadett Gyorgy; Peter Bakonyi; RehAn BukhAri; Ricardo Pinho; Istvan Boldogh; Gu Yaodong; Zsolt Radak
Journal:  Antioxidants (Basel)       Date:  2022-05-23

2.  The Effect of Vitamin D3 and Silver Nanoparticles on HaCaT Cell Viability.

Authors:  Samuela Cataldi; Maria Rachele Ceccarini; Federica Patria; Tommaso Beccari; Martina Mandarano; Ivana Ferri; Andrea Lazzarini; Francesco Curcio; Elisabetta Albi
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.